Sort
39,280 grants matching “leukemia”
Drug Combination Signatures for Prediction and Mitigation of Toxicity
$1,899,685Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · U54 · FY2019 · HG
Drug Combination Signatures for Prediction and Mitigation of Toxicity
$1,899,685Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · U54 · FY2017 · HG
Drug Combination Signatures for Prediction and Mitigation of Toxicity
$1,899,685Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · U54 · FY2016 · HG
Stem Cells and Aging
$1,899,280Peter J Quesenberry · Rhode Island Hospital · P20 · FY2021 · GM
Complexity, Cooperation and Community in Cancer
$1,899,177John Lowengrub · University Of California-Irvine · U54 · FY2020 · CA
Admixture analysis of acute lymphoblastic leukemia in African American children: the ADMIRAL Study
$1,898,254Logan G Spector · University Of Minnesota · R01 · FY2020 · CA
Signal Transduction In Mast Cells
$1,897,493Reuben P. Siraganian · National Institute Of Dental & Craniofacial Research · Z01 · FY2008 · DE
MSKCC Pilot Center for Precision Disease Modeling
$1,896,733Scott W Lowe · Sloan-Kettering Inst Can Research · U54 · FY2017 · OD
Immune Reconstitution
$1,896,251Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Clinical Research Support for the CCR
$1,895,729Robert Wiltrout · Division Of Basic Sciences - Nci · ZID · FY2011 · CA
Molecular Pathways to Thynmic Lymphoma and Leukemia
$1,895,397A Thomas Look · Dana-Farber Cancer Inst · P01 · FY2013 · CA
Women's Health Initiative Cancer Survivor Cohort
$1,894,768Garnet L. Anderson · Fred Hutchinson Cancer Research Center · UM1 · FY2013 · CA
Targeted Sphingolipid Metabolism for Treatment of AML
$1,894,532Thomas P Loughran · University Of Virginia · P01 · FY2024 · CA
Biodefense Project
$1,891,936Martha S Linet · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA
Environmental and Molecular Epidemiology of Childhood Leukemia
$1,891,869Patricia A Buffler · University Of California Berkeley · R01 · FY2010 · ES
Genetics and Genomics of Leiomyosarcoma (LMS): Improved understanding of cancer biology and new approaches to diagnosis and treatment
$1,890,694Scott Michael Schuetze · University Of Michigan At Ann Arbor · P50 · FY2025 · CA
Function of RUNX1 in diverse Down syndrome tissues
$1,890,079Mary A Allen · University Of Colorado · R01 · FY2021 · HL
Hematopoietic Stem Cell Transplant for GATA2 Deficiency
$1,886,562Dennis Hickstein · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Repository Services for epidemiology studies
$1,886,169David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2016 · CA
Roles and Regulation of wild-type and mutant forms of p53
$1,885,586Carol Prives · Columbia Univ New York Morningside · P01 · FY2020 · CA
Roles and Regulation of wild-type and mutant forms of p53
$1,885,586Carol Prives · Columbia Univ New York Morningside · P01 · FY2021 · CA
Roles and Regulation of wild-type and mutant forms of p53
$1,885,586Carol Prives · Columbia Univ New York Morningside · P01 · FY2018 · CA
IATRONGENIC CAUSES OF CANCER
$1,885,473University Of Southern California · P01 · FY2001 · CA
GVL without GVHD across HLA barriers: Translational Studies
$1,884,598Megan Sykes · Massachusetts General Hospital · P01 · FY2007 · CA
Immune Modulation/Hematopoietic Cell Transplantation
$1,883,752Robert Jon Soiffer · Dana-Farber Cancer Inst · U19 · FY2009 · AI